Clarivate Plc 16A.F Stock
Clarivate Plc Price Chart
Clarivate Plc 16A.F Financial and Trading Overview
Clarivate Plc stock price | 6.6 EUR |
Previous Close | 7.9 EUR |
Open | 8 EUR |
Bid | 8 EUR x N/A |
Ask | 8.8 EUR x N/A |
Day's Range | 8 - 8 EUR |
52 Week Range | 6.5 - 13.7 EUR |
Volume | 220 EUR |
Avg. Volume | 3 EUR |
Market Cap | 5.57B EUR |
Beta (5Y Monthly) | 1.099148 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.37 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 31.5 EUR |
16A.F Valuation Measures
Enterprise Value | 11.35B EUR |
Trailing P/E | N/A |
Forward P/E | 10.126582 |
PEG Ratio (5 yr expected) | 1.88 |
Price/Sales (ttm) | 2.1222827 |
Price/Book (mrq) | 0.97087383 |
Enterprise Value/Revenue | 4.321 |
Enterprise Value/EBITDA | 11.676 |
Trading Information
Clarivate Plc Stock Price History
Beta (5Y Monthly) | 1.099148 |
52-Week Change | -31.62% |
S&P500 52-Week Change | 20.43% |
52 Week High | 13.7 EUR |
52 Week Low | 6.5 EUR |
50-Day Moving Average | 7.43 EUR |
200-Day Moving Average | 8.85 EUR |
16A.F Share Statistics
Avg. Volume (3 month) | 3 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 675.76M |
Float | 513.32M |
Short Ratio | N/A |
% Held by Insiders | 9.59% |
% Held by Institutions | 92.42% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -151.75% |
Operating Margin (ttm) | 10.10% |
Gross Margin | 64.42% |
EBITDA Margin | 37.00% |
Management Effectiveness
Return on Assets (ttm) | 0.98% |
Return on Equity (ttm) | -42.70% |
Income Statement
Revenue (ttm) | 2.63B EUR |
Revenue Per Share (ttm) | 3.9 EUR |
Quarterly Revenue Growth (yoy) | -5.00000000000000000000000000000000% |
Gross Profit (ttm) | 1.71B EUR |
EBITDA | 972M EUR |
Net Income Avi to Common (ttm) | -4061700096 EUR |
Diluted EPS (ttm) | -6.26 |
Quarterly Earnings Growth (yoy) | -37.39% |
Balance Sheet
Total Cash (mrq) | 364.2M EUR |
Total Cash Per Share (mrq) | 0.54 EUR |
Total Debt (mrq) | 4.98B EUR |
Total Debt/Equity (mrq) | 71.6 EUR |
Current Ratio (mrq) | 0.902 |
Book Value Per Share (mrq) | 8.24 |
Cash Flow Statement
Operating Cash Flow (ttm) | 669.4M EUR |
Levered Free Cash Flow (ttm) | 378.86M EUR |
Profile of Clarivate Plc
Country | Germany |
State | N/A |
City | London |
Address | 70 St. Mary Axe |
ZIP | EC3A 8BE |
Phone | 44 20 7433 4000 |
Website | https://www.clarivate.com |
Industry | Information Technology Services |
Sector(s) | Technology |
Full Time Employees | 11600 |
Clarivate Plc, an information, analytics, and workflow company, provides structured information and analytics for discovery, development, protection, commercialization, and measurement of scientific research, innovations, and brands. The company operates through three segments: Academia and Government, Life Sciences and Healthcare, and Intellectual Property. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ProQuest One, Pivot, Polaris, eBook Central, Vegs, Alma, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis products for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs; and Real World Data, Dialog, Drug Safety Triager, and healthcare and data solutions. The company also provides Derwent products, which include Derwent Innovation, Innography, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; and CompuMark products, such as trademark screening, searching, and watching products and services. It serves government and academic institutions, and life science and healthcare companies in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.
Q&A For Clarivate Plc Stock
What is a current 16A.F stock price?
Clarivate Plc 16A.F stock price today per share is 6.6 EUR.
How to purchase Clarivate Plc stock?
You can buy 16A.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Clarivate Plc?
The stock symbol or ticker of Clarivate Plc is 16A.F.
Which industry does the Clarivate Plc company belong to?
The Clarivate Plc industry is Information Technology Services.
How many shares does Clarivate Plc have in circulation?
The max supply of Clarivate Plc shares is 668.14M.
What is Clarivate Plc Price to Earnings Ratio (PE Ratio)?
Clarivate Plc PE Ratio is now.
What was Clarivate Plc earnings per share over the trailing 12 months (TTM)?
Clarivate Plc EPS is -1.37 EUR over the trailing 12 months.
Which sector does the Clarivate Plc company belong to?
The Clarivate Plc sector is Technology.